(FRLN) – Management Changes
-
Freeline Therapeutics Holdings (FRLN) announces restructuring organization and pausing development of FLT190 to extend cash runway into Q2 2024
-
Freeline Therapeutics Holdings (FRLN) Appoints Paul Schneider as Chief Financial Officer
-
-
-
-
-
Back to FRLN Stock Lookup